School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, P.R. China.
School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou, Guangdong 510006, P.R. China.
Int J Mol Med. 2021 Aug;48(2). doi: 10.3892/ijmm.2021.4990. Epub 2021 Jun 29.
MicroRNA (miR)‑29b is a key tumor regulator. It can inhibit tumor cell proliferation, induce apoptosis, suppress tumor invasion and migration, thus delaying tumor progression. Our previous studies revealed an increased level of miR‑29b in hepatoma 22 (H22) cells in ascites tumor‑bearing mice. The present study investigated the effect of miR‑29b on proliferation and apoptosis of hepatocellular carcinoma ascites H22 cells and its association with the transforming growth factor‑β1 (TGF‑β1) signaling pathway and p53‑mediated apoptotic pathway. Briefly, H22 cells were transfected with miR‑29b‑3p (hereinafter referred to as miR‑29b) mimic or miR‑29b inhibitor. MTS cell proliferation assay and flow cytometry were used to analyze cell viability and apoptosis. The expression change of the TGF‑β1 signaling pathway and p53‑mediated apoptotic pathway were detected by reverse transcription‑quantitative PCR, western blotting and immunofluorescence. Furthermore, cells were treated with exogenous TGF‑β1 and TGF‑β1 small interfering RNA to evaluate the crosstalk between TGF‑β1 and p53 under miR‑29b regulation. The overexpression of miR‑29b decreased cell viability, increased cell apoptosis, activated the TGF‑β1 signaling pathway and p53‑mediated apoptotic pathway. Conversely, these effects were reversed by the miR‑29b inhibitor. Moreover, the effect of miR‑29b mimic was further increased after treating cells with exogenous TGF‑β1. The activation of the TGF‑β1 signaling pathway and p53‑mediated apoptotic pathway induced by miR‑29b overexpression were reversed by TGF‑β1 inhibition. In summary, these data indicated that miR‑29b has an important role in proliferation and apoptosis of H22 cells by regulating the TGF‑β1 signaling pathway, the p53‑dependent apoptotic pathway, and the crosstalk between TGF‑β1 and p53.
微小 RNA(miR)-29b 是一种关键的肿瘤调节因子。它可以抑制肿瘤细胞增殖,诱导细胞凋亡,抑制肿瘤侵袭和迁移,从而延缓肿瘤进展。我们之前的研究表明,在腹水荷瘤小鼠的肝癌 22(H22)细胞中,miR-29b 的水平升高。本研究探讨了 miR-29b 对肝癌腹水 H22 细胞增殖和凋亡的影响及其与转化生长因子-β1(TGF-β1)信号通路和 p53 介导的凋亡通路的关系。简要地说,将 miR-29b-3p(以下称为 miR-29b)模拟物或 miR-29b 抑制剂转染 H22 细胞。采用 MTS 细胞增殖试验和流式细胞术分析细胞活力和凋亡。通过逆转录-定量 PCR、western blot 和免疫荧光检测 TGF-β1 信号通路和 p53 介导的凋亡通路的表达变化。此外,用外源性 TGF-β1 和 TGF-β1 小干扰 RNA 处理细胞,以评估 miR-29b 调节下 TGF-β1 与 p53 之间的相互作用。miR-29b 的过表达降低了细胞活力,增加了细胞凋亡,激活了 TGF-β1 信号通路和 p53 介导的凋亡通路。相反,miR-29b 抑制剂则逆转了这些作用。此外,用外源性 TGF-β1 处理细胞后,miR-29b 模拟物的作用进一步增强。miR-29b 过表达诱导的 TGF-β1 信号通路和 p53 介导的凋亡通路的激活被 TGF-β1 抑制所逆转。综上所述,这些数据表明,miR-29b 通过调节 TGF-β1 信号通路、p53 依赖性凋亡通路以及 TGF-β1 与 p53 之间的相互作用,在 H22 细胞的增殖和凋亡中发挥重要作用。